StockData
Colgate Palmolive Co logo

Colgate Palmolive Co (CL) stock

CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3033% above fair value
$95.29+2.13 (+2.29%)

Close on Oct 30, 2026Market cap $75.96BP/E 37.4Yield 2.18%

Earnings

Colgate Palmolive's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 29, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$5.36B
+4.9% on a year earlier
Base Business EPS, Q2 FY2026
$0.99
$0.92 a year earlier
Latest guidance
Reaffirmed
Jul 31, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Colgate Palmolive's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Jan 29, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 30, 2026before the open––––Release
Q2 FY2026ended Jun 30, 2026Jul 31, 2026before the open$5.36B+4.9%$0.86$0.99Release
Q1 FY2026ended Mar 31, 2026May 1, 2026before the open$5.32B–$0.80$0.97Release
Q4 FY2025ended Dec 31, 2025Jan 30, 2026before the open$5.23B–-$0.05$0.95Release
Q3 FY2025ended Sep 30, 2025Oct 31, 2025before the open––$0.91$0.91Release
Q2 FY2025ended Jun 30, 2025Aug 1, 2025before the open$5.11B+1.0%$0.91$0.92Release
Q1 FY2025ended Mar 31, 2025Apr 25, 2025before the open––$0.85$0.91Release
Q4 FY2024ended Dec 31, 2024Jan 24, 2025after the close––$0.90$0.91Release
Q2 FY2024ended Jun 30, 2024Jul 26, 2024before the open$5.06B+4.9%$0.89$0.91Release
Q1 FY2024ended Mar 31, 2024Apr 26, 2024before the open$5.07B+6.2%$0.83$0.86Release
Q4 FY2023ended Dec 31, 2023Jan 26, 2024before the open$4.95B+6.9%$0.87$0.87Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Colgate Palmolive's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net salesGAAPFY2026+2% – +6%+2% – +6%ReaffirmedJul 31, 2026
net salesFY2026+2% – +6%–NewJan 30, 2026
organic sales growthnon-GAAPFY2026+1% – +4%+1% – +4%ReaffirmedJul 31, 2026

Guidance history

Every forecast Colgate Palmolive put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Jul 31, 2026organic sales growthFY2026+1% – +4%Reaffirmed
Jul 31, 2026net salesFY2026+2% – +6%Reaffirmed
May 1, 2026organic sales growthFY2026+1% – +4%Reaffirmed
May 1, 2026net salesFY2026+2% – +6%New
Jan 30, 2026organic sales growthFY2026+1% – +4%New
Jan 30, 2026net salesFY2026+2% – +6%New
Oct 31, 2025gross profit marginFY202560.1%New
Oct 31, 2025gross profit marginFY202560.1%New
Oct 31, 2025organic sales growthFY2025+1% – +2%Lowered
Aug 1, 2025organic sales growthFY2025+2% – +4%New
Apr 25, 2025organic sales growthFY2025+2% – +4%New
Jan 24, 2025earnings per share growthFY2024+10% – +11%Raised
Jan 24, 2025net sales growthFY2024+3% – +5%Raised
Jan 24, 2025organic sales growthFY2024+7% – +8%Raised
Jul 26, 2024earnings per share growthFY2024+8% – +11%New
Jul 26, 2024net sales growthFY2024+2% – +5%New
Jul 26, 2024organic sales growthFY2024+6% – +8%Raised
Apr 26, 2024organic sales growthFY2024+5% – +7%Raised
Apr 26, 2024net sales growthFY2024+2% – +5%Raised
Jan 26, 2024organic sales growthFY2024+3% – +5%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Colgate Palmolive filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. News
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. News
  13. News
  14. Results
  15. Results